SCHEMBL5337208

SCHEMBL5337208

O=C1COc2ccccc2N1C(=O)Oc1ccccc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BCHE P06276 1/20 0.49
CBX7 O95931 2/20 0.46
CDYL2 Q8N8U2 2/20 0.46
CDYL Q9Y232 2/20 0.46
CDY1; CDY1B Q9Y6F8 2/20 0.46
ALDH1A1 P00352 4/20 0.45
MEN1 O00255 3/20 0.44
KMT2A Q03164 3/20 0.44
L3MBTL1 Q9Y468 1/20 0.43
TSHR P16473 2/20 0.42
ALOX12 P18054 1/20 0.42
LMNA P02545 1/20 0.41
POLB P06746 1/20 0.41
P2RX4 Q99571 1/20 0.41
HSD17B3 P37058 1/20 0.40
HTT P42858 1/20 0.40
USP2 O75604 1/20 0.40
KDM4E B2RXH2 1/20 0.40
GAA P10253 1/20 0.40
MAPT P10636 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28265104 0.86 MEN1 (0.52) CBX7CDYL2CDYLCDY1; CDY1BALDH1A1
SCHEMBL28265078 0.82 MEN1 (0.46) CBX7CDYL2CDYLCDY1; CDY1BALDH1A1
SCHEMBL28263925 0.82 TSHR (0.47) CBX7CDYL2CDYLCDY1; CDY1BALDH1A1
SCHEMBL5227565 0.82 KMT2A (0.50) CBX7CDYL2CDYLCDY1; CDY1BALDH1A1
SCHEMBL5418613 0.80 ALDH1A1 (0.39) BCHEALDH1A1TSHRUSP2MAPT
SCHEMBL30687393 0.78 NOTUM (0.59) BCHEALDH1A1MEN1KMT2AL3MBTL1
SCHEMBL5808642 0.78 NOTUM (0.59) BCHEALDH1A1MEN1KMT2AL3MBTL1
SCHEMBL18964807 0.75 NOTUM (0.45) BCHEALDH1A1KMT2ALMNAPOLB
SCHEMBL6958446 0.75 KMT2A (0.53) CBX7CDYL2CDYLCDY1; CDY1BALDH1A1
SCHEMBL9608993 0.73 BCHE (0.53) BCHEALDH1A1MEN1KMT2ATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7202255-B2 Substituted [1,4] benzodioxino[2,3-e] isoindole derivatives, method for preparing and pharmaceutical compositions containing same LES LABORATOIRES SERVIER (FR) 2007-04-10 US disclosed
US-20060040930-A1 Novel substituted [1,4] benzodioxino[2,3-e] isoindole derivatives, method for preparing and pharmaceutical compositions containing same LES LABORATOIRES SERVIER (FR) 2006-02-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060040930-A1 Novel substituted [1,4] benzodioxino[2,3-e] isoindole derivatives, method for preparing and pharmaceutical compositions containing same CYP11B2, CYP2F1, CYP3A43 BCHE 997/4885CBX7 874/4885CDYL2 1073/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.